Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.330
-0.020 (-0.85%)
Aug 14, 2025, 11:16 AM - Market open
Apyx Medical Revenue
Apyx Medical had revenue of $11.37M in the quarter ending June 30, 2025, a decrease of -6.39%. This brings the company's revenue in the last twelve months to $46.51M, down -5.14% year-over-year. In the year 2024, Apyx Medical had annual revenue of $48.10M, down -8.11%.
Revenue (ttm)
$46.51M
Revenue Growth
-5.14%
P/S Ratio
1.95
Revenue / Employee
$211,418
Employees
220
Market Cap
88.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.10M | -4.25M | -8.11% |
| Dec 31, 2023 | 52.35M | 7.84M | 17.61% |
| Dec 31, 2022 | 44.51M | -4.01M | -8.26% |
| Dec 31, 2021 | 48.52M | 20.81M | 75.08% |
| Dec 31, 2020 | 27.71M | -524.00K | -1.86% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
APYX News
- 5 days ago - Apyx Medical Corporation (APYX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Apyx Medical Corporation Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 14 days ago - Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 2 months ago - Renuvion® Brings Real Transformations to the Runway at Miami Swim Week - PRNewsWire
- 3 months ago - Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™ - GlobeNewsWire
- 3 months ago - Apyx Medical Corporation (APYX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Renuvion Introduces Television Star Dolores Catania as Chief of Confidence - PRNewsWire
- 3 months ago - Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures - GlobeNewsWire